Abstract
Glioblastoma multiforme (GBM) is the most advanced and aggressive form of primary brain tumor, and finding effective therapies remains a pharmaceutical challenge and an unmet medical need. In this context, the combination of medicine and nanotechnology offers stimulating potential for more efficient approaches against GBM, due to the adjustable physicochemical properties of nanoparticles,…